COVID-19 mRNA Vaccine (SYS6006)

About CSPC Innovation Pharmaceutical

CSPC Innovation Pharmaceutical's mission is to establish CSPC as a global, innovation-driven biopharmaceutical leader by developing and commercializing novel therapeutics. Its key achievement is building a substantial and maturing clinical pipeline, primarily in oncology, which is now advancing into late-stage trials and contributing to the parent group's valuation of over $45 billion. The strategy centers on leveraging internal R&D across multiple modalities, strategic external partnerships, and the parent company's formidable commercial and manufacturing scale to efficiently bring differentiated medicines to the large Chinese and international markets.

Therapeutic Areas

Other COVID-19 Prevention Drugs